Enlivex Therapeutics Stock Analysis

Enlivex Stock Analysis Notes

About 19.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enlivex Therapeutics recorded a loss per share of 0.98. The entity last dividend was issued on the 6th of March 2019. The firm had 1:8 split on the 6th of March 2019. Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel. Enlivex Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 71 people. To learn more about Enlivex Therapeutics call the company at 972 2 670 8072 or check out https://www.enlivex.com.

Enlivex Therapeutics Investment Alerts

Enlivex Therapeutics Upcoming and Recent Events

Enlivex Largest EPS Surprises

View All Earnings Estimates

Enlivex Therapeutics Thematic Classifications

Enlivex Stock Institutional Investors

Note, although Enlivex Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Enlivex Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.4 M.

Enlivex Profitablity

Management Efficiency

Enlivex Therapeutics has return on total asset (ROA) of (0.2746) % which means that it has lost $0.2746 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6117) %, meaning that it created substantial loss on money invested by shareholders. Enlivex Therapeutics' management efficiency ratios could be used to measure how well Enlivex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.83 in 2024. Return On Capital Employed is likely to drop to -1 in 2024. At this time, Enlivex Therapeutics' Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 187.9 K in 2024, whereas Total Assets are likely to drop slightly above 30.6 M in 2024.

Technical Drivers

As of the 2nd of December, Enlivex Therapeutics shows the Standard Deviation of 5.22, variance of 27.2, and Mean Deviation of 3.53. Enlivex Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Enlivex Therapeutics standard deviation and potential upside to decide if Enlivex Therapeutics is priced favorably, providing market reflects its regular price of 1.14 per share. Given that Enlivex Therapeutics is a hitting penny stock territory we advise to closely look at its jensen alpha.

Enlivex Therapeutics Price Movement Analysis

Enlivex Therapeutics Outstanding Bonds

Enlivex Therapeutics Predictive Daily Indicators

Enlivex Therapeutics Forecast Models

Enlivex Therapeutics' time-series forecasting models are one of many Enlivex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enlivex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Enlivex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enlivex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enlivex Therapeutics. By using and applying Enlivex Stock analysis, traders can create a robust methodology for identifying Enlivex entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enlivex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enlivex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Enlivex Therapeutics stock analysis indicators help investors evaluate how Enlivex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Enlivex Therapeutics shares will generate the highest return on investment. By understating and applying Enlivex Therapeutics stock analysis, traders can identify Enlivex Therapeutics position entry and exit signals to maximize returns.

When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.